Catalyst Wire Dossier Catalyst Wire Dossier

Docetaxel Polymeric Micelle (PM)

docetaxel · Samyang Biopharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Docetaxel Polymeric Micelle (PM), covering 2017-05-01 to 2017-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC [Phase 2]

See pricing